A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants

Inclusion Criteria Participants who meet all of the following criteria will be eligible to participate in this study: * Between 18 and 75 years old. Both men and women can participate, but women may make up to 70% of the participants. * BMI of 30 or higher, or a BMI between 27 and 30 with at least one related health condition such as prediabetes, high blood pressure, abnormal cholesterol levels, fatty liver, or sleep apnea due to being overweight. * HbA1c level below 6.5% and fasting blood sugar levels below 126 mg/dL. * Have tried and failed to lose weight through diet and exercise at least once before the study and must have had a stable body weight (less than a 5% change) in the 90 days before the study. * Participants and their partners must not plan to become pregnant or donate sperm/eggs during the study and for 90 days after. They must agree to use effective contraception for at least 6 months prior to screening and continue their chosen contraception method throughout the study. Women who could become pregnant must have a negative pregnancy test 24 hours before the first dose of study drug. * Willing to maintain a stable diet and exercise routine during the study and keep a diary of their activities. * Understand the study procedures, be willing to follow the study rules strictly, and sign a consent form voluntarily. Exclusion Criteria Participants who meet any of the following criteria will be excluded from this study: * Known or suspected hypersensitivity to GL…